fashion -WSS

fashion

author：knowledge 2025-09-29 18:59:41 - browse：7384

After earning her doctorate in cell biology at the University of Pennsylvania in June, Sierra Collins did what many freshly minted Ph.D.s. do — she went looking for a job at a biotech company. But what was supposed to be a straightforward search has turned into an odyssey.

Collins has applied for more than 53 positions (and counting). Like a good scientist, she’s gathering data along the way and uses a spreadsheet to track each company’s size and therapeutic focus, as well as whether she was referred for the position and how far she made it through the application process. So far, those efforts have been unsuccessful.

“I try my best not to take it personally. These are companies that are trying to find an employee who’s going to help them achieve their business goals,” Collins said. “But it is pretty discouraging just repeatedly getting turned down, especially at later stages of the interview process.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

hotspot

WSS

Biohaven protein

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

David Sabatini, ex

AI used to predict Covid

First Opinion Podcast: What happens when kids become caregivers?

Reconstructing family trees of blood cells may help predict disease

knowledge

fashion

knowledge

Supreme Court strikes down use of affirmative action

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

How one medical school became remarkably diverse

Latest bird flu infection made farmworker sicker than earlier cases

In Memoriam: Notable people who died in 2023

Merck CEO won’t testify in Senate, citing no expertise in drug prices

The high cost of giving birth even with insurance

David Sabatini, ex

focus

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Insmed lung disease drug hits target in key Phase 3 trial

Philips to halt sales of sleep apnea machines in U.S.

Adam's Biotech Scorecard: Do Sarepta's exon

Biohaven protein

Syphilis numbers in the United States reach record heights

Wikipedia

hotspot

hotspot

focus